Clinical Trial Update: Efficacy and Safety of Chinese Medicine JCM-16021 for Diarrhea-predominant Irritable Bowel Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update reports on efficacy and safety of the Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome in Phase 2 and Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• JCM-16021

Snippet

Sponsor: ZhaoXiang Bian | Conditions: Irritable Bowel Syndrome | Phase 2, Phase 3 | Status: UNKNOWN